Based on 5 analysts giving stock ratings to Nutex Health Inc in the past month.
In the current month, NUTX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NUTX average Analyst price target in the last month is 283.000.
Based on analysts' estimates, NUTX EPS is projected to reach 5.708 in FY2026Q3, following reported EPS of 9.583 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 9.58, while Nutex Health IncNUTX's earnings per share (EPS) for the previous quarter was USD 6.70. EPS for the next quarter is expected at USD 5.71.